Posts tagged T cell medicated tutor immunity
In conversation with Allen Krantz

As the founder, president and CEO of Advanced Proteome Therapeutics (TSX-V:APC; Frankfurt:OE8), Dr. Allen Krantz has successfully transitioned a career in academia to the biotech sector. From 1968 to 1974, he was a member of the Faculty of Chemistry at the State University of New York at Stony Brook and from 1974 to 1981 he held appointments in both the Department of Chemistry and the Department of Pharmacological Sciences in the Medical School at the same institution. Then he began an extensive career in industry, with senior research postings at Syntex Research Canada and RedCell, the forerunner of ConjuChem, including a stint as the Directeur Scientifique of the European office in France in the 1990s. Dr. Krantz was responsible for transforming the company’s program to a practical focal point on human serum albumin as a carrier of drugs. In 2007, Advanced Proteome was created through a reverse takeover. In this interview with, Dr. Krantz discusses the company’s unique approach to developing a potential anti-cancer therapeutic.

Read More